Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 17,683,885 $ 24,907,963
Accounts receivable, net 259,562 2,291,533
Other receivables   526,070
Prepaid expenses and other current assets 236,160 495,178
Total Current Assets 18,179,607 28,220,744
Intangible assets, net   2,946,610
Goodwill   463,000
Property and equipment, net   44,756
Deferred offering costs 10,000 10,000
Total Assets 18,189,607 31,685,110
Current Liabilities:    
Accounts payable - suppliers 562,877 1,844,544
Accounts payable - trade 323,402 659,362
Accrued expenses and other current liabilities 376,409 2,493,287
Deferred revenue 146,339 395,914
Notes payable 1,509 151,336
Total Current Liabilities 1,410,536 5,544,443
Contingent consideration   613,000
Notes payable, non-current portion 77,391 77,407
Total Liabilities 1,487,927 6,234,850
Commitments and contingencies (Note 5)
Stockholders' Equity:    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of June 30, 2022 and December 31, 2021
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,401,252 and 14,253,948 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 144 143
Additional paid-in capital 52,719,709 52,030,907
Accumulated deficit (36,018,173) (26,580,790)
Total Stockholders' Equity 16,701,680 25,450,260
Total Liabilities and Stockholders' Equity $ 18,189,607 $ 31,685,110